Published in Clin Chest Med on July 25, 2012
Metabolomic Endotype of Asthma. J Immunol (2015) 0.85
Protein and microRNA biomarkers from lavage, urine, and serum in military personnel evaluated for dyspnea. BMC Med Genomics (2014) 0.80
The Correlation between Chitin and Acidic Mammalian Chitinase in Animal Models of Allergic Asthma. Int J Mol Sci (2015) 0.75
Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 30.27
The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy (2004) 13.16
Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society. Am J Respir Crit Care Med (2000) 8.09
Lebrikizumab treatment in adults with asthma. N Engl J Med (2011) 8.07
Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med (2009) 7.17
T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med (2009) 7.11
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med (2005) 6.96
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol (2007) 6.33
A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med (2007) 6.02
Increased nitric oxide in exhaled air of asthmatic patients. Lancet (1994) 5.39
Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med (2000) 5.27
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet (2001) 5.25
Asthma: defining of the persistent adult phenotypes. Lancet (2006) 4.78
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis. J Clin Invest (2003) 4.08
Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet (2008) 4.06
Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet (2008) 3.71
Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med (2004) 3.64
Reciprocal regulation of the nitric oxide synthase/arginase balance in mouse bone marrow-derived macrophages by TH1 and TH2 cytokines. Eur J Immunol (1995) 3.17
Protection from experimental asthma by an endogenous bronchodilator. Science (2005) 3.17
Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol (2008) 3.15
The codependence of angiogenesis and chronic inflammation. FASEB J (1997) 3.02
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985) (2007) 2.83
Distinguishing severe asthma phenotypes: role of age at onset and eosinophilic inflammation. J Allergy Clin Immunol (2004) 2.80
Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J (2003) 2.70
The mouse trap: It still yields few answers in asthma. Am J Respir Crit Care Med (2006) 2.68
Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell (2007) 2.65
Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc Natl Acad Sci U S A (1993) 2.64
Airway responsiveness in mild to moderate childhood asthma: sex influences on the natural history. Am J Respir Crit Care Med (2008) 2.61
Expression and activity of pH-regulatory glutaminase in the human airway epithelium. Am J Respir Crit Care Med (2002) 2.54
Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells. Am J Physiol Endocrinol Metab (2001) 2.50
Bronchodilator S-nitrosothiol deficiency in asthmatic respiratory failure. Lancet (1998) 2.47
The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med (2007) 2.44
A multivariate analysis of risk factors for the air-trapping asthmatic phenotype as measured by quantitative CT analysis. Chest (2008) 2.38
Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax (2007) 2.37
Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol (2010) 2.27
Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol (2010) 2.20
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation (1999) 2.14
Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol (2007) 2.11
The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med (2000) 2.07
Working hypothesis to redefine endothelial progenitor cells. Leukemia (2007) 2.03
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01
Oxidative and nitrosative events in asthma. Free Radic Biol Med (2003) 1.97
Pulmonary strategies of antioxidant defense. Am Rev Respir Dis (1989) 1.94
Arginase induction by suppressors of nitric oxide synthesis (IL-4, IL-10 and PGE2) in murine bone-marrow-derived macrophages. Biochem Biophys Res Commun (1995) 1.89
Diminished lipoxin biosynthesis in severe asthma. Am J Respir Crit Care Med (2005) 1.87
Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol (2000) 1.84
S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem J (1998) 1.83
Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest (2006) 1.83
Pathophysiology of severe asthma. J Allergy Clin Immunol (2000) 1.80
Differential effects of fluticasone propionate on allergen-evoked bronchoconstriction and increased urinary leukotriene E4 excretion. Am Rev Respir Dis (1993) 1.74
Increase in urinary leukotriene LTE4 levels in acute asthma: correlation with airflow limitation. Thorax (2004) 1.73
Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med (2005) 1.72
Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol (2001) 1.69
Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol (2001) 1.68
Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med (2010) 1.68
Obesity and asthma: an association modified by age of asthma onset. J Allergy Clin Immunol (2011) 1.64
Urinary excretion of inflammatory mediators during allergen-induced early and late phase asthmatic reactions. Clin Exp Allergy (1998) 1.60
Epithelial damage and angiogenesis in the airways of children with asthma. Am J Respir Crit Care Med (2006) 1.58
High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax (2002) 1.57
Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol (2005) 1.56
Polyamines: from molecular biology to clinical applications. Ann Med (1991) 1.54
Acute effects of aerosolized S-nitrosoglutathione in cystic fibrosis. Am J Respir Crit Care Med (2002) 1.51
Interferon gamma and interleukin 4 stimulate prolonged expression of inducible nitric oxide synthase in human airway epithelium through synthesis of soluble mediators. J Clin Invest (1997) 1.48
Antioxidant responses to oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol (2002) 1.45
Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. Am J Respir Crit Care Med (2008) 1.45
Acid stress in the pathology of asthma. J Allergy Clin Immunol (2004) 1.45
Rapid loss of superoxide dismutase activity during antigen-induced asthmatic response. Lancet (2000) 1.43
Redox control of asthma: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal (2010) 1.43
Alterations of the arginine metabolome in asthma. Am J Respir Crit Care Med (2008) 1.40
Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am J Respir Crit Care Med (2007) 1.36
Nitrotyrosine proteome survey in asthma identifies oxidative mechanism of catalase inactivation. J Immunol (2006) 1.34
Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med (1995) 1.31
The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. J Allergy Clin Immunol (2004) 1.26
Induced sputum eicosanoid concentrations in asthma. Am J Respir Crit Care Med (1999) 1.24
3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry (1999) 1.24
Acute and chronic effects of a 5-lipoxygenase inhibitor in asthma: a 6-month randomized multicenter trial. Zileuton Study Group. J Allergy Clin Immunol (1996) 1.23
S-nitrosoglutathione breakdown prevents airway smooth muscle relaxation in the guinea pig. Am J Physiol Lung Cell Mol Physiol (2000) 1.22
The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med (2002) 1.22
S-nitrosoglutathione reductase: an important regulator in human asthma. Am J Respir Crit Care Med (2009) 1.22
Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest (2005) 1.22
Mast cell contribution to angiogenesis related to tumour progression. Clin Exp Allergy (2004) 1.21
Arginine in asthma and lung inflammation. J Nutr (2004) 1.19
Genome screen for asthma and bronchial hyperresponsiveness: interactions with passive smoke exposure. J Allergy Clin Immunol (2005) 1.19
Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol (2005) 1.19
Th1- and Th2-dependent endothelial progenitor cell recruitment and angiogenic switch in asthma. J Immunol (2007) 1.18
Role of ornithine as a proline precursor in healing wounds. J Surg Res (1993) 1.16
Noninvasive markers of airway inflammation in asthma. Clin Transl Sci (2009) 1.15
The relationship between the free pool of proline and collagen content in human liver cirrhosis. J Clin Invest (1970) 1.15
Vascular endothelial growth factor up-regulation and bronchial wall remodelling in asthma. Clin Exp Allergy (2005) 1.14
Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress. Am J Respir Crit Care Med (1999) 1.14
Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J (2007) 1.12
Temporal association of nitric oxide levels and airflow in asthma after whole lung allergen challenge. J Appl Physiol (1985) (2003) 1.12
Determinants of exhaled breath condensate pH in a large population with asthma. Chest (2010) 1.12
Human peripheral blood eosinophils induce angiogenesis. Int J Biochem Cell Biol (2005) 1.11
Effects of the menstrual cycle on lung function variables in women with asthma. Am J Respir Crit Care Med (2009) 1.10
Oxidants and asthma. Thorax (2004) 1.08
Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: correction by inhaled corticosteroid in vivo. Am J Physiol (1997) 1.08
Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol (1999) 1.06
Expired nitric oxide as a marker for childhood asthma. J Pediatr (1997) 1.06
The arginine-arginase balance in asthma and lung inflammation. Eur J Pharmacol (2006) 1.06
Lung function in adults with stable but severe asthma: air trapping and incomplete reversal of obstruction with bronchodilation. J Appl Physiol (1985) (2007) 2.83
Features of severe asthma in school-age children: Atopy and increased exhaled nitric oxide. J Allergy Clin Immunol (2006) 2.30
Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program. J Allergy Clin Immunol (2010) 2.27
Severe asthma: lessons learned from the National Heart, Lung, and Blood Institute Severe Asthma Research Program. Am J Respir Crit Care Med (2011) 1.76
Gene expression in relation to exhaled nitric oxide identifies novel asthma phenotypes with unique biomolecular pathways. Am J Respir Crit Care Med (2014) 1.69
Exhaled-breath condensate pH can be safely and continuously monitored in mechanically ventilated patients. Respir Care (2006) 1.59
Detrimental effects of environmental tobacco smoke in relation to asthma severity. PLoS One (2011) 0.97
A neonatal mouse model of intestinal perforation: investigating the harmful synergism between glucocorticoids and indomethacin. J Pediatr Gastroenterol Nutr (2007) 0.96
Increased systemic inflammation overnight correlates with insulin resistance among children evaluated for obstructive sleep apnea. Sleep Breath (2011) 0.81
Hemoglobin and nitric oxide. N Engl J Med (2003) 0.81